RISK-AWARE RESTRICTED OUTCOME LEARNING FOR INDIVIDUALIZED TREATMENT REGIMES OF SCHIZOPHRENIA

成果类型:
Article
署名作者:
Zhu, Shuying; Shen, Weining; Fu, Haoda; Qu, Annie
署名单位:
University of California System; University of California Irvine; Eli Lilly
刊物名称:
ANNALS OF APPLIED STATISTICS
ISSN/ISSBN:
1932-6157
DOI:
10.1214/23-AOAS1836
发表日期:
2024
页码:
1319-1336
关键词:
composite outcomes models efficacy trials DESIGN
摘要:
Schizophrenia is a severe mental disorder that distorts patients' perception of reality, and its treatment with antipsychotics can lead to significant side effects. Despite the heterogeneity in patient responses to treatments, most existing studies on individualized treatment regimes only focus on optimizing treatment efficacy, disregarding potential negative effects. To fill this gap, we propose a restricted outcome weighted learning method that optimizes efficacy outcomes while adhering to individual -level negative effect constraints. Our method is developed for multistage treatment decision problems that include single -stage decision as a special case. We propose an efficient learning algorithm that utilizes the difference -of -convex algorithm and the Lagrange multiplier to solve nonconvex optimization with nonconvex risk constraints. We also establish theoretical properties, including Fisher consistency and strong duality results, for the proposed method. We apply our method to a clinical study to design effective schizophrenia treatment [Stroup et al. (Schizophr. Bull. 29 (2003) 15-31)] and find that our approach reduces side -effect risk by at least 22.5% and improves efficacy by at least 26.3% compared to competing methods. In addition, we discover that certain covariates, such as the PANSS score, clinician global impressions severity score, and BMI, have a significant impact on controlling side effects and determining optimal treatment recommendations. These results are valuable in identifying subgroups of patients who need special attention when prescribing more aggressive treatment plans.
来源URL: